473 related articles for article (PubMed ID: 15180715)
21. pH, healing rate, and symptom relief in patients with GERD.
Huang JQ; Hunt RH
Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
[TBL] [Abstract][Full Text] [Related]
22. Use of intragastric pH monitoring in gastroesophageal reflux disease.
Katz PO
Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):277-87. PubMed ID: 15722241
[TBL] [Abstract][Full Text] [Related]
23. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
Ortiz A; Martínez de Haro LF; Parrilla P; Molina J; Bermejo J; Munitiz V
Br J Surg; 1999 Nov; 86(11):1472-4. PubMed ID: 10583299
[TBL] [Abstract][Full Text] [Related]
24. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication.
Mainie I; Tutuian R; Agrawal A; Adams D; Castell DO
Br J Surg; 2006 Dec; 93(12):1483-7. PubMed ID: 17051602
[TBL] [Abstract][Full Text] [Related]
25. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
Soto Pérez JC; Icaza ME; Vargas F; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2003; 68(2):113-9. PubMed ID: 15127647
[TBL] [Abstract][Full Text] [Related]
26. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.
Katzka DA; Castell DO
Am J Gastroenterol; 1994 Jul; 89(7):989-91. PubMed ID: 8017396
[TBL] [Abstract][Full Text] [Related]
27. The diagnosis of gastroesophageal reflux disease.
Dughera L; Navino M; Cassolino P; Pellicano R
Minerva Gastroenterol Dietol; 2007 Jun; 53(2):143-52. PubMed ID: 17557042
[TBL] [Abstract][Full Text] [Related]
28. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
[TBL] [Abstract][Full Text] [Related]
29. Catheter-based pH monitoring: use in evaluation of gastroesophageal reflux disease symptoms (on and off therapy).
DeVault KR
Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):289-306. PubMed ID: 15722242
[TBL] [Abstract][Full Text] [Related]
30. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
Peng S; Xiong LS; Xiao YL; Wang AJ; Lin JK; Hu PJ; Chen MH
Chin Med J (Engl); 2010 Aug; 123(15):2012-7. PubMed ID: 20819534
[TBL] [Abstract][Full Text] [Related]
31. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
Issing WJ; Tauber S; Folwaczny C; Reichel O
Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
[TBL] [Abstract][Full Text] [Related]
32. "Refractory GERD": acid, nonacid, or not GERD?
Vaezi MF
Am J Gastroenterol; 2004 Jun; 99(6):989-90. PubMed ID: 15180714
[TBL] [Abstract][Full Text] [Related]
33. CON: Treatment with PPIs should not be preceded by pH monitoring in patients suspected of laryngeal reflux.
Vaezi MF
Am J Gastroenterol; 2006 Jan; 101(1):8-10. PubMed ID: 16405526
[No Abstract] [Full Text] [Related]
34. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
[TBL] [Abstract][Full Text] [Related]
35. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy.
Bredenoord AJ; Weusten BL; Timmer R; Conchillo JM; Smout AJ
Am J Gastroenterol; 2006 Mar; 101(3):453-9. PubMed ID: 16464226
[TBL] [Abstract][Full Text] [Related]
36. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
Weigt J; Kandulski A; Büsch F; Malfertheiner P
Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
[TBL] [Abstract][Full Text] [Related]
37. Current medical management of gastroesophageal reflux disease.
Locke GR
Thorac Surg Clin; 2005 Aug; 15(3):369-75. PubMed ID: 16104127
[TBL] [Abstract][Full Text] [Related]
38. Control of intragastric pH and its relationship to gastroesophageal reflux disease outcomes.
Katz PO; Johnson DA
J Clin Gastroenterol; 2011 Oct; 45(9):748-54. PubMed ID: 21694609
[TBL] [Abstract][Full Text] [Related]
39. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
Lacy BE; Chehade R; Crowell MD
Am J Gastroenterol; 2011 Sep; 106(9):1604-11. PubMed ID: 21691342
[TBL] [Abstract][Full Text] [Related]
40. 24-hour esophageal pH monitoring in children with pathological acid gastroesophageal reflux: primary and secondary to food allergy. Part I. Intraesophageal pH values in distal channel; preliminary study and control studies--after 1, 2, 4 and 9 years of clinical observation as well as dietary and pharmacological treatment.
Semeniuk J; Kaczmarski M
Adv Med Sci; 2007; 52():199-205. PubMed ID: 18217419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
